CLINICAL_TRIALS
trial_result
· 2009-02-12
Clinical Trial Update: A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus [Phase 2]
Summary
Phase 2 safety and efficacy study of alefacept for moderate to severe erosive mucosal lichen planus was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Lichen Planus | Phase 2 | Status: TERMINATED